Species differences in the intrinsic clearance (CL int ) and the enzymes involved in the metabolism of pyrethroid pesticides were examined in rat and human hepatic microsomes. The pyrethroids bifenthrin, S-bioallethrin, bioresmethrin, ␤-cyfluthrin, cypermethrin, cis-permethrin, and trans-permethrin were incubated in rat and human hepatic microsomes in the presence or absence of NADPH. Metabolism was measured using a parent depletion approach. The CL int of the pyrethroids was 5-to 15-fold greater in rat relative to human microsomes except for trans-permethrin, which was approximately 45% greater in human microsomes. The metabolism of bifenthrin, S-bioallethrin, and cis-permethrin in rat and human hepatic microsomes was solely the result of oxidative processes. The metabolism of bioresmethrin and cypermethrin in human hepatic microsomes was solely the result of hydrolytic processes. Bioresmethrin and cypermethrin in rat hepatic microsomes and ␤-cyfluthrin and trans-permethrin in microsomes from both species were metabolized by both oxidative and hydrolytic pathways. The metabolism of transpermethrin was reduced when incubated with its diastereomer, cispermethrin, in both rat and human hepatic microsomes. Rat cytochrome P450 (P450) isoforms that showed activity toward several pyrethroids included CYP1A1, CYP1A2, CYP2C6, CYP2C11, CYP3A1, and CYP3A2. Human P450 isoforms that showed activity toward multiple pyrethroids were CYP2C8, CYP2C9, CYP2C19, and CYP3A4. Species-specific differences in metabolism may result in variable detoxification of pyrethroids, which may in turn result in divergent neurotoxic outcomes. These species differences and isomer interactions in metabolism of pyrethroids should be considered when assessing the potential adverse health effects of pyrethroid pesticides.
Pyrethroids can be classified as Type I or Type II compounds (Soderlund et al., 2002) . Type I pyrethroids are esters of primary or secondary alcohols. Type II pyrethroids are esters of secondary alcohols with a cyano group at the ␣-carbon of the alcohol moiety (Fig. 1) . Soderlund and Casida (1977) , using mouse liver microsomes, examined how the structure of a pyrethroid influences its metabolic pathway. Of the Type I pyrethroids examined, the trans isomers were the most rapidly metabolized, primarily by hydrolysis. The cis isomers were metabolized at a relatively slower rate, primarily by oxidation. The Type II pyrethroids studied had the lowest overall metabolic rate, and the metabolism generally occurred by both pathways.
The signs of acute toxicity in rats differ between Type I and Type II pyrethroids (Ray and Forshaw, 2000; Soderlund et al., 2002) . Type II pyrethroids are generally more potent than Type I pyrethroids. Symptoms in rats administered Type I pyrethroids include aggression and hypersensitivity, general and fine tremor, convulsive twitching, coma, and death. Type II pyrethroids elicit pawing and burrowing, salivation, coarse tremor, increased extensor tone, writhing convulsions, and death. The site of action of pyrethroids is the voltagedependent sodium channel, but the chloride, calcium, and other channels may also be targets (Ray and Forshaw, 2000; Soderlund et al., 2002; Shafer and Meyer, 2004; Ray and Fry, 2006) .
The parent pyrethroid is generally believed to be the neurotoxic entity (Soderlund et al., 2002) as metabolism decreases its potency. The characteristic neurotoxic effects of the pyrethroid resmethrin observed in rats after p.o. administration were not observed after i.v. administration of its hydrolyzed products, cis-and trans-chrysanthemic acid or 5-benzyl-3-furylmethyl alcohol (White et al., 1976) . Intracerebral administration of several pyrethroids in mice confirmed the neurotoxic findings after their i.p. administration in mice and p.o. or i.v. administration in rats (Lawrence and Casida, 1982) . Levels of deltamethrin, a Type II pyrethroid, in rat brain correlate with the onset of neurotoxicity in this species (Rickard and Brodie, 1985) . More recently, Anand et al. (2006b) reported that the severity of neurotoxicity of deltamethrin was greater in 10-than in 40-day-old rats because of its limited metabolism in the younger animals. Pyrethroid metabolism is an important determinant of the toxicological outcome after exposure.
Pyrethroids are generally formulated as a mixture of the isomers. The possibility exists that enantiomers or diastereomers of a pyrethroid may interact metabolically or dynamically. This interaction could lead to several outcomes. Because the metabolism of pyrethroids is believed to be a detoxification process, the most adverse outcome of this isomer interaction would be competitive inhibition of the metabolism of the most neurotoxic isomer. This could lead to enhanced neurotoxicity. If competitive metabolic inhibition by the isomers occurs, it would be expected to be dose-dependent. This may be a high-dose effect, which may occur occupationally but most likely not after environmentally low exposures to pyrethroids.
The objective of this study was to determine the intrinsic clearance (CL int ), a measurement of metabolic rate, of several Type I and II pyrethroids in rat and human hepatic microsomes; to assess the relative role of oxidative and hydrolytic pathways of these pyrethroids; to investigate the potential interaction of diastereomers of permethrin at the metabolic level; and to screen rat and human P450 isoforms for their ability to metabolize pyrethroids. A better understanding of the metabolic differences between rodents and humans may allow for a more accurate extrapolation of the rodent pyrethroid toxicity data to human exposures.
Materials and Methods
Chemicals. The pyrethroids bifenthrin (100% cis), S-bioallethrin (100% trans), bioresmethrin (96% trans/2% cis), ␤-cyfluthrin (67% trans/33% cis), -cyhalothrin (100% cis), cypermethrin (49% cis/51% trans), cis-permethrin (100% cis), trans-permethrin (96% trans/4% cis), and resmethrin (30% cis/ 70% trans) were purchased from Chem Service Inc. (West Chester, PA). Structures of the pyrethroids used in this study are shown in Fig. 3 . Purity exceeded 98% for all the pyrethroids except trans-permethrin (94% trans/4% cis) and bioresmethrin (96% trans/2% cis). The commercial formulation of permethrin (40:60, cis/trans) was a gift from FMC Corporation (Philadelphia, PA). Labeled cis-and trans-permethrin ( 13 C 6 -phenoxy) were purchased from Cambridge Isotope Laboratories (Andover, MA). These pyrethroids were chosen to study because they are registered for use on food crops. Solvents, including acetone, hexanes, pentane (Thermo Fisher Scientific, Waltham, MA), and methanol (VWR, West Chester, PA), were pesticide grade. Sucrose, EDTA (disodium salt dihydrate), KCl, N-(2-hydroxyethyl)piperazine-NЈ-(2-ethanesulfonic acid) (sodium salt), glycerol, dithiothreitol, Trizma base, and NADPH were purchased from Sigma-Aldrich (St. Louis, MO). Methanol (pesticide grade) was purchased from Honeywell Burdick & Jackson (Meskegon, MI). Ammonium acetate was from Fluka Chemicals (St. Louis, MO). Unless otherwise specified, chemicals used were of the highest grade commercially available.
Animals. Long-Evans rats (male, approximately 70 days old, 275-299 g) were purchased from Charles River Laboratories, Inc. (Wilmington, MA) and allowed to acclimate for a minimum of 4 days in an Association for the Assessment and Accreditation of Laboratory Animal Care-approved facility. The Long-Evans rat was used because of ongoing collaborations that are investigating the neurotoxicity of pyrethroids in this strain (Wolansky et al., 2006) . The overall goal of our collaborative project is to develop biologically based dose-response models for the pyrethroids. Therefore, we found it necessary in our metabolism studies to use the same rat strain as that used in the neurotoxicity studies. All of the animal procedures were approved by the Institutional Animal Care and Use Committee of the National Health and Environmental Effects Research Laboratory. Rats were housed in pairs in polypropylene cages lined with heat-treated pine shavings. Temperature, humidity, and photoperiod were maintained at 21 Ϯ 2°C, 50 Ϯ 10%, in 12-h light/12-h dark cycles, respectively. Feed (Purina Rodent Chow 5001; Barnes Supply Co., Durham, NC) and tap water were provided ad libitum.
Rat Hepatic Microsomal Preparation. Rat hepatic microsomes were a pool of livers from six animals. Three pools of microsomes were prepared using a total of 18 animals. Pools of microsomes were prepared because of our interest in comparing metabolism data across a series of environmental chemicals, including pyrethroid pesticides, and minimizing experimental variability. Our concern was not that of assessing interanimal variability. Rats were anesthetized with CO 2 and sacrificed via cardiac puncture. Livers were removed, weighed, and homogenized (1:4 w/v) in ice-cold buffer containing 250 mM sucrose, 0.5 mM EDTA, 0.25 mM KCl, 10 mM N-(2-hydroxyethyl)-piperazine-NЈ-(2-ethanesulfonic acid), 1 mM dithiothreitol, and 10% glycerol. Homogenates were centrifuged at 12,000g for 21.5 min in a Beckman Coulter, Inc. (Fullerton, CA) J2-21M Induction Drive Centrifuge using a JA-17 rotor. The supernatant was removed and centrifuged at 105,000g for 60 min in a Beckman Instruments XL-80 Ultracentrifuge using a 50.2 Ti rotor. The cytosolic supernatant was discarded. The pellet was washed by resuspending it in homogenization buffer and centrifuging for a second time at 105,000g for 60 min. After the wash, the pellet was resuspended in 25 ml of homogenization buffer. Microsomal protein was quantified using the Bio-Rad protein assay (Bio-Rad, Hercules, CA) standardized with bovine serum albumin. Microsomes were stored at Ϫ80°C until use.
Human Microsomes. Pooled human adult liver microsomes were purchased from CellzDirect (Phoenix, AZ; lot number HMMC-PL020, a mixed gender pool of 15), Cedra (Austin, TX; lot number 821-2, a mixed gender pool of 15), and XenoTech, LLC (Lenexa, KS; lot number 051022, a mixed gender pool of 50). Using human microsomes from three different sources limited the potential bias in preparation and processing the samples. Each pool of microsomes was used in a separate experiment. Microsomes were stored at Ϫ80°C until use.
Rat and Human P450s. Supersomes (microsomes) containing specific rat (CYP1A1, CYP1A2, CYP2A1, CYP2B1, CYP2C6, CYP2C11, CYP2C12, CYP2C13, CYP2D1, CYP2D2, CYP3A1, and CYP3A2) or human (CYP1A1, CYP1A2, CYP2B6, CYP2C8, CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C19, and CYP3A4) P450 isoforms were purchased from BD Biosciences (Woburn, MA). The isoform is expressed from a rat or human P450 cDNA using a baculovirus-infected cell system. The microsomes prepared from this system also contain P450 reductase. The P450 content ranged from 1000 to 2000 pmol/ml. Determination of K m and V max in Rat Hepatic Microsomes. Estimates of K m and V max were determined in rat hepatic microsomes for bifenthrin, S-bioallethrin, bioresmethrin, cis-permethrin, trans-permethrin, and a 40:60 FIG. 3 . Structures of the pyrethroids used in this study. The structure of cypermethrin is shown in Fig. 1 . Bioresmethrin is the trans isomer of resmethrin (which is not shown).
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at ASPET Journals on November 6, 2017 dmd.aspetjournals.org cis/trans permethrin mixture. This determination was done to ensure pyrethroid concentrations in the parent depletion assays described below were Ͻ ϽK m . The assays were conducted in duplicate for each of the three pools of microsomes (n ϭ 3) by measuring the disappearance of parent compounds over 10 min. Each assay tube consisted of 3.5 ml of 0.1 M Trizma buffer, pH 7.4, 1 mg/ml microsomal protein, and 1 mg/ml NADPH. This mixture was preincubated at 37°C for 10 min. Assays were initiated by the addition of pyrethroid in 25 l of methanol at time 0 to attain final pyrethroid concentrations of 0.1, 1, 5, 10, 20, or 50 M. At time 0, 2, 6, 8, and 10 min, 250-l aliquots were removed from the mixture and dispensed into silanized 16 ϫ 100-mm culture tubes containing 2 ml of ice-cold 5% acetone/pentane. To assess analyte recovery, 50 ng of trans-permethrin ( 13 C 6 -phenoxy) in methanol was added to the solvent/ sample mixtures as a surrogate. Parent pyrethroids were extracted from the buffer by vortexing for 5 min followed by centrifuging at 1300g for 5 min. The tubes were placed into a methanol/dry ice bath to freeze the aqueous layer. The unfrozen organic solvent was poured into 13 ϫ 100-mm culture tubes. The extraction was repeated twice more with 2 ml of 5% acetone/ pentane each time. Extracts were combined and dried under a stream of nitrogen. Samples were reconstituted in 1 ml of methanol. As an internal standard, 50 ng of cis-permethrin ( 13 C 6 -phenoxy) in methanol was added to each sample. Control incubations were performed in Trizma buffer with NADPH in the absence of microsomal protein to ensure that metabolism of the pyrethroids was enzymatic. There was no significant loss of pyrethroid in the control incubations. Concentration of substrate was determined by high-performance liquid chromatography (LC)/tandem mass spectrometry analysis (see below for details) over the time course and converted to moles of substrate remaining. Substrate remaining was converted to product formed and plotted versus time to produce a reaction velocity. Plotting reaction velocities against initial concentrations yielded K m and V max estimates (JMP version 6; SAS Institute, Cary, NC) for each pyrethroid.
Determination of Metabolic Rate Constants in Rat and Human Microsomes. In vitro metabolic rate constants were determined for bifenthrin, S-bioallethrin, bioresmethrin, ␤-cyfluthrin, cypermethrin, cis-permethrin, and trans-permethrin in rat and human hepatic microsomes. A 0.5 M concentration for the pyrethroids was used except for S-bioallethrin (1 M). The K m values for the pyrethroids were determined as described above with the rat hepatic microsomes, except for ␤-cyfluthrin and cypermethrin. The K m values ranged from 3.7 to 31.1 M. Based on these results, we assumed that a concentration of 0.5 M for ␤-cyfluthrin and cypermethrin was below the rat hepatic microsomal K m values for these two compounds. A similar assumption was made for the pyrethroid concentrations used in the human hepatic microsomal incubations.
Microsomal metabolism assays with the pyrethroids were conducted using the parent compound depletion approach as described above. Using this approach, only the metabolic loss of parent chemical is quantitated. This approach was taken in part because it is generally believed the parent pyrethroid is the neurotoxic entity, whereas its metabolism results in detoxification of the compound. In brief, pyrethroid in 25 l of methanol was added to a 1-ml incubation mixture (37°C) of 0.1 M Trizma buffer, pH 7.4, 1 mg/ml microsomal protein, and 1 mg/ml NADPH. At 0, 4, and 8 min, 250-l aliquots of incubate were removed and handled as described above. Assays to assess the microsomal hydrolysis of the pyrethroids were conducted as described above but in the absence of NADPH. Each incubation, with or without NADPH, was conducted in duplicate using the three different pools of microsomes (n ϭ 3).
Calculation of Metabolic Rate Constants and Intrinsic Hepatic Clearance Rates. First-order metabolic rate constants (k) were determined from the linear regression of the natural log of the percentage pyrethroid remaining versus time. The slope of the regression line equals k (min Ϫ1 ). At substrate concentrations significantly below K m , the clearance of a chemical is constant (Iwatsubo et al., 1997) and can be calculated using k (Obach, 1999) . CL int was estimated using the following equation: CL int ϭ k (min Ϫ1 ) ⅐ ml incubation/mg microsomes ⅐ mg microsomes/g liver ⅐ g liver/kg b.wt. (Obach et al., 1997 (Obach et al., , 1999 .
Metabolism of Pyrethroids by Rat and Human P450 Isoforms. The capacity of selected rat and human P450 isoforms to metabolize bifenthrin, S-bioallethrin, bioresmethrin, ␤-cyfluthrin, -cyhalothrin, cypermethrin, cispermethrin, trans-permethrin, and resmethrin was examined. In brief, 10 l of a 50 M pyrethroid stock solution (final concentration, 0.5 M) was added to a 1-ml incubation (37°C) mixture containing 0.1 M Trizma buffer, pH 7.4, supersomes containing 10 pmol of P450, and 1 mg/ml NADPH. Each incubation was conducted in triplicate (n ϭ 3). At 0 and 10 min, 250-l aliquots were removed from the mixture and handled as described above and analyzed for parent compound.
Analysis and Quantification of Pyrethroids. An Applied Biosystems (Foster City, CA) API 4000 LC/tandem mass spectrometry fronted with an Agilent Technologies (Santa Clara, CA) 1100 Series LC system was used to analyze the pyrethroids. Isocratic elution of the pyrethroids off an Agilent Zorbax Eclipse XDB-C18 column (3 ϫ 150 mm, 3.5 m) was accomplished with a 98%:2% methanol/5 mM ammonium acetate solution flowing at 400 l/min. The mass spectrometer was operated with the turbo ion spray/atmospheric pressure ionization source. Positive ionization was used for all the compounds, and the analytes were identified using transition ion pairs and retention times.
Pyrethroid concentration was calculated using a 5-point calibration curve prepared in sample matrix containing cis-permethrin ( 13 C 6 -phenoxy) as an internal standard. The concentrations of the extracted pyrethroids were determined by the ratio of internal standard response to analyte response. Calibration standards ranged from 0.01 to 0.6 M. However, curves were generally limited to 2 orders of magnitude. Samples with chemical concentrations outside the calibration curve were reanalyzed with an appropriate curve. In addition, samples with surrogate concentrations of trans-permethrin ( 13 C 6 -phenoxy) that varied greater than 20% of expected concentrations were reanalyzed.
Method recoveries were determined by spiking preincubated (37°C) microsomal preparations, excluding NADPH, with individual pyrethroids at a final concentration of 0.5 M. The incubations were vortexed for 5 s and immediately extracted as described previously. Percent recoveries and coefficients of variations were 84 to 108% and 5 to 10%, respectively (Table 1) .
Statistical Analysis. A one-sample t test was used to assess whether pyrethroid clearance in the absence of NADPH was significantly different from 0 ( p Ͻ 0.05) (GraphPad Instat, version 3.05; GraphPad Software Inc., San Diego, CA). An unpaired t test was used to assess whether the pyrethroid clearance values in the presence or absence of NADPH were significantly different ( p Ͻ 0.05). The percentage metabolism of pyrethroids by rat and human P450s was assessed by a one-sample t test to assess whether the value was significantly different from 0 ( p Ͻ 0.05).
Results
Estimates of K m and V max for Type I Pyrethroids in Rat Hepatic Microsomes. The K m s ranged from 3.7 (cis-permethrin) to 31.1 M (S-bioallethrin) with respective 95% confidence intervals of 1.6 to 9.2 and 8.38 to 233.2 M (Table 2) . A similar trend was observed for V max with cis-permethrin having the lowest (0.14 nmol/min/mg microsomal protein) and S-bioallethrin the highest (4.4 nmol/min/mg microsomal protein) value. The relative ranking from lowest to highest K m and V max was cis-permethrin Ͻ bioresmethrin Ͻ bifenthrin Ͻ trans-permethrin Ͻ S-bioallethrin. Hepatic clearance values, esti- (Table 3) were similar to the values when cis-or transpermethrin were incubated alone ( Table 2 ). The hepatic clearance (V max /K m ) estimates for cis-and trans-permethrin in the mixture (Table 3) were greater than the estimates in the single isomer experiments ( Table 2 ). The differences are largely accounted for by the greater V max for cis-permethrin and lower K m for trans-permethrin in the mixture. The sum of cis-and trans-permethrin concentrations was used to calculate the total permethrin metabolic parameters. The total permethrin K m was lower than the values for the cis and trans isomers. The total permethrin V max was 2 times greater than the cis value.
CL int of Pyrethroids from Rat and Human Hepatic Microsomes. The CL int values of the Type I pyrethroids examined in rat hepatic microsomes, with one exception, exceeded those in human microsomes (Table 4) . With the exception of trans-permethrin, the CL int of these pyrethroids was 5-to 15-fold greater in rat relative to human hepatic microsomes. The CL int of trans-permethrin was 45% greater in human than in rat microsomes. The pyrethroids with the highest CL int in rat and human microsomes were of the trans configuration. These pyrethroids are bioresmethrin and trans-permethrin, respectively. In rat microsomes, the rank order from highest to lowest CL int was bioresmethrin, S-bioallethrin, cis-permethrin, trans-permethrin, and bifenthrin. In human microsomes, the rank order was trans-permethrin, bioresmethrin, S-bioallethrin, cis-permethrin, and bifenthrin.
The contributions of oxidative and hydrolytic pathways were determined by comparing the metabolism of the pyrethroids in the presence or absence of NADPH. The contributions of the oxidative mechanisms were calculated by subtracting the non-NADPH (or hydrolytic) contribution from the overall metabolic rate. The metabolism of bifenthrin, S-bioallethrin, and cis-permethrin was attributed to the oxidative pathway because they lacked significant metabolism in the absence of NADPH (Table 4) . Trans-permethrin was metabolized by both oxidative and hydrolytic processes in rat and human hepatic microsomes. However, hydrolysis of trans-permethrin was greater in rat microsomes, whereas oxidative metabolism predominated in human microsomes. The metabolism of bioresmethrin by rat hepatic microsomes was a combination of oxidative and hydrolytic mechanisms, similar to trans-permethrin. However, in human microsomes, NADPH-dependent metabolism of bioresmethrin was limited.
The CL int of ␤-cyfluthrin and cypermethrin, determined by summation of all the co-occurring isomers, was greater in the rat relative to human hepatic microsomes (Table 5) . However, the differences in CL int between rat and human microsomes were much smaller than those of the Type I pyrethroids (Table 5) , varying by a factor of 3. Cypermethrin and ␤-cyfluthrin are primarily metabolized through oxidative mechanisms in rat and hydrolytic mechanisms in human hepatic microsomes.
CL int of a Permethrin Mixture. The impact of incubating a mixture of pyrethroid isomers on the CL int of the individual isomers was examined using permethrin (40:60, cis/trans). The CL int of cispermethrin incubated as either an individual isomer or in the mixture was 10-fold greater or more in rat than in human hepatic microsomes (Table 6 ). Trans-permethrin was cleared more quickly by human than rat hepatic microsomes when incubated as an individual isomer. The CL int of trans-permethrin was similar between microsomes from both species when incubated in the mixture. However, the CL int of transpermethrin in the mixture decreased by 40% in rat and 64% in human hepatic microsomes. The CL int of total permethrin was approximately 3-fold greater in rat than in human hepatic microsomes.
Metabolism of Pyrethroids by Rat and Human P450s. Nine pyrethroids (six Type I, three Type II) were screened for metabolism in the presence of NADPH by 12 rat and 9 human P450s (Tables 7 and  8) . Overall, more rat P450 isoforms had the ability to metabolize these pyrethroids to a significant extent than the human P450 isoforms. With the rat P450s, setting a level of 25% or more metabolism of parent pyrethroid in 10 min, the isoforms that showed activity were CYP1A1 (9/9 pyrethroids), CYP1A2 (3/9), CYP2C6 (9/9), CYP2C11 
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at ASPET Journals on November 6, 2017 dmd.aspetjournals.org (8/9), CYP2D1 (1/9), CYP3A1 (8/9), and CYP3A2 (6/9). With the human P450s, the isoforms that showed activity were CYP1A1 (1/9 pyrethroids), CYP1A2 (1/9), CYP2B6 (1/9), CYP2C8 (3/9), CYP2C9*1 (4/9), CYP2C9*2 (2/9), CYP2C19 (9/9), and CYP3A4 (2/9).
Discussion
Rodents have in general a higher xenobiotic metabolic rate than humans. This is evident in the present study as the CL int of six of the seven pyrethroids examined was greater in rat than in human hepatic microsomes. The greater CL int in rat hepatic microsomes may be explained by greater abundance, specificity, or catalytic activity of the pyrethroid-metabolizing enzymes than in human hepatic microsomes. Hepatic P450s have a major role in the metabolism of pyrethroids. The hepatic P450 content is greater in rats than humans when expressed either in terms of grams of liver (2.5-3-fold greater) or milligrams of microsomal protein (1.5-fold greater) (Kremers et al., 1981) . Hepatic and extrahepatic carboxylesterases metabolize pyrethroids (Anand et al., 2006a; Godin et al., 2006; Nishi et al., 2006; Ross et al., 2006; Crow et al., 2007) . The in vitro hydrolysis of esfenvalerate is approximately 2-fold greater for rat hydrolase A than human carboxylesterase-1, two abundant hepatic carboxylesterases (Godin et al., 2006) . However, there are exceptions, in that the CL int of trans-permethrin (present study) and deltamethrin (Godin et al., 2006) was greater in human than rat hepatic microsomes. Although the metabolic rate of xenobiotics is typically greater for rodents, at a minimum, in vitro experiments should be conducted to ensure that this hypothesis is correct. If assumed, misleading extrapolations from rodents to humans may occur in risk assessments.
A species difference in the two major enzymatic pathways of in vitro pyrethroid metabolism was detected. Metabolism of bioresmethrin and cypermethrin in human hepatic microsomes did not require NADPH, suggesting that it was solely by hydrolysis. In rat hepatic microsomes, metabolism of these two pyrethroids was a combination of oxidation and hydrolysis, with the former pathway being predominant. Similar results have been reported with deltamethrin in human and rat microsomes (Anand et al., 2006a; Godin et al., 2006) . The qualitative and quantitative differences between rat and human hepatic microsomes in pyrethroid metabolism suggest that the sole use of rat metabolism data in the development of pharmacokinetic models of this pesticide for human extrapolation should be approached guardedly.
There is a general but not exact relationship between pyrethroid structure and its pathway and rate of metabolism. In mouse liver microsomes, primary alcohol esters of trans-substituted cyclopropanecarboxylic acids are the most rapidly metabolized pyrethroids, primarily by hydrolysis (Soderlund and Casida, 1977) . Bioresmethrin and trans-permethrin have this structure but do not follow the same metabolic pathway in microsomes. Bioresmethrin was only metabolized by hydrolysis in human hepatic microsomes. However, in rat at ASPET Journals on November 6, 2017 dmd.aspetjournals.org hepatic microsomes, oxidation of bioresmethrin was slightly greater than hydrolysis. With trans-permethrin, hydrolysis was slightly greater and lower than oxidation in rat and human hepatic microsomes, respectively. Soderlund and Casida (1977) reported that pyrethroids with primary alcohol esters of cis-substituted cyclopropanecarboxylic acids are metabolized slower than their trans-substituted isomers. This was evident with cis-and trans-permethrin in rat and human microsomes. Pyrethroids with a secondary alcohol ester tended to be metabolized by oxidation in mouse liver microsomes (Soderlund and Casida, 1977) . S-Bioallethrin has this structure and likewise, in rat and human hepatic microsomes, was only metabolized by oxidation. Pyrethroids with a cyano group on the ␣-carbon of the alcohol moiety (Type II compound) were metabolized the slowest in mouse hepatic microsomes, and with a few exceptions, there was no clear preference in their metabolic pathway (Soderlund and Casida, 1977) . In the present study, the metabolic rate of the Type II pyrethroids examined, ␤-cyfluthrin and cypermethrin, was on the lower end of the spectrum. There were clear species differences in their microsomal metabolic pathways. Oxidation was predominant in rat hepatic microsomes, and hydrolysis was predominant in human hepatic microsomes for both pyrethroids. Similar results were reported with the Type II pyrethroid deltamethrin (Godin et al., 2006) . However, the Type II pyrethroid esfenvalerate, which lacks a cyclopropane ring, was metabolized primarily by oxidation in both rat and human microsomes (Godin et al., 2006) . This suggests that Type II pyrethroids with a cyclopropane ring are more susceptible to hydrolysis than oxidation in human hepatic microsomes. Several rat and human P450 isoforms consistently metabolized the pyrethroids screened in the present study. Rat CYP1A1 was very active toward the pyrethroids. However, CYP1A1 is expressed at low levels in rat liver (Martignoni et al., 2006) and is unlikely to have a major role in metabolizing pyrethroids. In rat small intestine, CYP1A1 is expressed more than in the liver (Zhang et al., 1996) . Thus, in rat small intestine, CYP1A1 may metabolize pyrethroids and limit their absorption. The most abundant P450 family in rat liver is CYP2C, with CYP2C11 being the predominant isoform in male rat (Martignoni et al., 2006) . Of the rat isoforms, CYP2C11 and CYP2C6 had the most activity toward the pyrethroids screened. CYP2C11 is most likely the predominant isoform that metabolizes pyrethroids in male rat liver. In human liver, approximately 20 and 30% of total P450 is composed of the CYP2C and CYP3A families, respectively (Shimada et al., 1994) . Isoforms CYP2C8 and CYP2C9 are the major forms of the CYP2C family in human liver, whereas CYP2C19, which has the greatest activity toward the pyrethroids, is expressed to a minor extent (Martignoni et al., 2006) . In human liver, CYP3A4 and CYP2C9 are most likely the isoforms that metabolize the pyrethroids. A potential explanation for the relatively low mammalian pyrethroid toxicity is that there are several P450 isoforms in the liver and other tissues that metabolize this class of pesticides to less toxic forms. This is in addition to the activity of carboxylesterases toward the pyrethroids.
Pyrethroids are metabolized not only in liver microsomes but also in hepatic cytosol, serum (or plasma), and small intestinal microsomes (Anand et al., 2006a; Crow et al., 2007; Godin et al., 2007) . Rat and human hepatic cytosol are approximately 2-fold less hydrolytically active toward trans-permethrin than the corresponding microsomes . Human small intestinal microsomes hydrolyzed trans-permethrin but not deltamethrin or bioresmethrin . Hydrolysis of trans-permethrin is slower in rat than in human small intestinal microsomes . Deltamethrin is hydrolyzed in rat serum and plasma (Anand et al., 2006a; Godin et al., 2007) . However, deltamethrin is not metabolized in human serum (Godin et al., 2007) because it lacks carboxylesterase activity (Li et al., 2005) . Because hepatic cytosol has pyrethroid hydrolytic activity, it may be necessary to take this into account along with hepatic microsomal activity for a better estimate of CL int . Finally, the observation that rat serum (plasma) is hydrolytically active toward the pyrethroids, whereas human serum is not, needs to be considered when extrapolating metabolic results from rat to human. Many pyrethroids are formulated as a mixture of isomers. Permethrin consists of two diastereomers (cis and trans) and four enantiomers. Pyrethroid isomers display different toxic potencies, which may be because of isomer-specific pharmacodynamic and pharmacokinetic processes. For example, in male mice the acute p.o. LD 50 of (ϩ)-cis-permethrin is 107 mg/kg but is Ͼ5000 mg/kg for (Ϫ)-cispermethrin (Miyamoto, 1976) . Pyrethroid isomers may interact at their site of metabolism and toxicity. This interaction could alter the toxicity of a mixture of isomers compared to a single isomer formulation. Results from this study suggest that cis-permethrin interacts with metabolism of trans-permethrin. The CL int of trans-permethrin in the presence of cis-permethrin was decreased 40 to 64% relative to its incubation as a single isomer in rat and human hepatic microsomes. The CL int of cis-permethrin was not similarly affected by transpermethrin in either rat or human hepatic microsomes. Because transpermethrin is hydrolyzed more readily in rat hepatic microsomes, this effect is not as great as in human hepatic microsomes. In human hepatic microsomes, the metabolism of trans-permethrin is more oxidative than hydrolytic. Because the metabolism of cis-permethrin is predominantly oxidative in this fraction, and thus slower, it may interact with trans-permethrin and decrease its metabolism, perhaps by competitive inhibition. Other than human P450 isoforms CYP2C9*1 and CYP3A4 and rat CYP3A1 for cis-permethrin and human CYP2C9*2 for trans-permethrin, the P450 isoforms screened were fairly consistent in metabolizing these two diastereomers. This in vitro effect on the CL int of pyrethroid isomers may potentially affect exposure-dose-response relationships in the risk assessment of commercial mixtures of pyrethroids.
In summary, several pyrethroids were metabolized at rates greater in rat than in human hepatic microsomes. Overall, the pyrethroids examined were metabolized by oxidation and hydrolysis. However, bifenthrin, S-bioallethrin, and cis-permethrin were metabolized predominantly by oxidation in both rat and human hepatic microsomes. In contrast, bioresmethrin and cypermethrin were metabolized primarily by hydrolysis in human hepatic microsomes. A metabolic interaction of cis-and trans-permethrin seems to have decreased the CL int of trans-permethrin. Of the P450 isoforms examined, rat CYP1A1, CYP2C6, CYP2C11, CPY3A1, and CYP3A2 and human CYP2C19 have the most pyrethroid-metabolizing activity. The potential for species differences and isomer interaction in the metabolism of pyrethroids should be considered in the toxicity assessment and development of pharmacokinetic and pharmacodynamic models for this class of pesticides.
